| Year |
Citation |
Score |
| 2020 |
Lee KW, Chung IJ, Ryu MH, Park YI, Nam BH, Oh HS, Lee KH, Han HS, Seo BG, Jo JC, Lee HR, Kim JW, Park SR, Cho SH, Kang YK, et al. Multicenter phase III trial of S-1 and cisplatin versus S-1 and oxaliplatin combination chemotherapy for first-line treatment of advanced gastric cancer (SOPP trial). Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. PMID 32596783 DOI: 10.1007/S10120-020-01101-4 |
0.357 |
|
| 2020 |
Keam B, Kang EJ, Ahn M, Ock C, Lee KW, Kwon JH, Yang Y, Choi YH, Kim MK, Ji JH, Yun T, Nam B, Kim S. Randomized phase II study of axitinib versus observation in patients with recurred or metastatic adenoid cystic carcinoma. Journal of Clinical Oncology. 38: 6503-6503. DOI: 10.1200/Jco.2020.38.15_Suppl.6503 |
0.335 |
|
| 2020 |
Ryu KW, Kim YW, Min JS, An JY, Yoon HM, Eom BW, Hur H, Lee YJ, Cho GS, Park Y, Jung MR, Park J, Hyung WJ, Jeong S, Han M, ... Nam B, et al. Laparoscopic sentinel node navigation surgery versus laparoscopic standard gastrectomy with lymph node dissection in early gastric cancer: Final three-year survival results of multicenter randomized controlled phase III trial (SENORITA trial). Journal of Clinical Oncology. 38: 4510-4510. DOI: 10.1200/Jco.2020.38.15_Suppl.4510 |
0.385 |
|
| 2019 |
Zhang HS, Lee EK, Jung YS, Nam BH, Park B. The binary presence or absence of lymph node metastasis or extrathyroidal extension is not associated with survival in papillary thyroid cancers: Implications for staging systems. Cancer Epidemiology. 63: 101589. PMID 31494519 DOI: 10.1016/J.Canep.2019.101589 |
0.322 |
|
| 2019 |
Eom BW, Yoon HM, Min JS, Cho I, Park JH, Jung MR, Hur H, Kim YW, Park YK, Nam BH, Ryu KW. Prospective Multicenter Feasibility Study of Laparoscopic Sentinel Basin Dissection after Endoscopic Submucosal Dissection for Early Gastric Cancer: SENORITA 2 Trial Protocol. Journal of Gastric Cancer. 19: 157-164. PMID 31245160 DOI: 10.5230/Jgc.2019.19.E12 |
0.341 |
|
| 2018 |
Kwon MJ, Lee SB, Han J, Lee JE, Lee JW, Gong G, Beitsch PD, Nam SJ, Ahn SH, Nam BH, Shin YK. BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancer. Plos One. 13: e0207155. PMID 30462685 DOI: 10.1371/Journal.Pone.0207155 |
0.385 |
|
| 2018 |
Eom BW, Kim S, Kim JY, Yoon HM, Kim MJ, Nam BH, Kim YW, Park YI, Park SR, Ryu KW. Survival Benefit of Perioperative Chemotherapy in Patients with Locally Advanced Gastric Cancer: a Propensity Score Matched Analysis. Journal of Gastric Cancer. 18: 69-81. PMID 29629222 DOI: 10.5230/Jgc.2018.18.E9 |
0.386 |
|
| 2018 |
Macalindong SS, Kim KH, Nam BH, Ryu KW, Kubo N, Kim JY, Eom BW, Yoon HM, Kook MC, Choi IJ, Kim YW. Effect of total number of harvested lymph nodes on survival outcomes after curative resection for gastric adenocarcinoma: findings from an eastern high-volume gastric cancer center. Bmc Cancer. 18: 73. PMID 29329569 DOI: 10.1186/S12885-017-3872-6 |
0.369 |
|
| 2018 |
Kim MJ, Kong SY, Nam BH, Kim S, Park YI, Park SR. A randomized phase II study of S-1 versus capecitabine as first-line chemotherapy in elderly metastatic gastric cancer patients with or without poor performance status: clinical and pharmacogenetic results. Pharmacogenetics and Genomics. 28: 23-30. PMID 29189588 DOI: 10.1097/Fpc.0000000000000320 |
0.391 |
|
| 2018 |
Kim YW, Nam B, Lee Y, Park Y, Lee SE, Jeong O, Lee JH, Yoon KY, Jeong S, Kwon OK, Kim T, Yu W, Kim Ys, Han M, Kim S, et al. Laparoscopy-assisted versus open D2 distal gastrectomy for advanced gastric cancer: Five year overall survival and morbidity results from a randomized phase II multicenter clinical trial (COACT 1001). Journal of Clinical Oncology. 36: 4041-4041. DOI: 10.1200/Jco.2018.36.15_Suppl.4041 |
0.355 |
|
| 2018 |
Hong YS, Kim SY, Lee JS, Nam B, Kim JE, Kim K, Park JO, Park YS, Baek JY, Kim T, Lee K, Ahn JB, Jung KH, Kim TW. Long-term results of the ADORE trial: Adjuvant oxaliplatin, leucovorin, and 5-fluorouracil (FOLFOX) versus 5-fluorouracil and leucovorin (FL) after preoperative chemoradiotherapy and surgery for locally advanced rectal cancer. Journal of Clinical Oncology. 36: 3501-3501. DOI: 10.1200/Jco.2018.36.15_Suppl.3501 |
0.394 |
|
| 2017 |
Kim SY, Yoon MJ, Park YI, Kim MJ, Nam BH, Park SR. Nomograms predicting survival of patients with unresectable or metastatic gastric cancer who receive combination cytotoxic chemotherapy as first-line treatment. Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. PMID 28828688 DOI: 10.1007/S10120-017-0756-Z |
0.394 |
|
| 2017 |
Park SR, Kim MJ, Nam BH, Kim CG, Lee JY, Cho SJ, Kong SY, Park YI. A randomised phase II study of continuous versus stop-and-go S-1 plus oxaliplatin following disease stabilisation in first-line chemotherapy in patients with metastatic gastric cancer. European Journal of Cancer (Oxford, England : 1990). 83: 32-42. PMID 28711577 DOI: 10.1016/J.Ejca.2017.06.008 |
0.382 |
|
| 2017 |
Kim YI, Kim MJ, Park SR, Kim HK, Cho SJ, Lee JY, Kim CG, Kim GH, Park MI, Nam BH, Park YI, Choi IJ. Effect of a Proton Pump Inhibitor on Tumor Bleeding Prevention in Unresectable Gastric Cancer Patients: a Double-Blind, Randomized, Placebo-Controlled Trial. Journal of Gastric Cancer. 17: 120-131. PMID 28680717 DOI: 10.5230/Jgc.2017.17.E15 |
0.333 |
|
| 2017 |
Han J, Choi YL, Kim H, Choi JY, Lee SK, Lee JE, Choi JS, Park S, Choi JS, Kim YD, Nam SJ, Nam BH, Kwon MJ, Shin YK. MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer. Breast Cancer Research and Treatment. PMID 28409241 DOI: 10.1007/S10549-017-4234-4 |
0.309 |
|
| 2017 |
Gong G, Kwon MJ, Han J, Lee HJ, Lee SK, Lee JE, Lee SH, Park S, Choi JS, Cho SY, Ahn SH, Lee JW, Cho SR, Moon Y, Nam BH, et al. A new molecular prognostic score for predicting the risk of distant metastasis in patients with HR+/HER2- early breast cancer. Scientific Reports. 7: 45554. PMID 28350001 DOI: 10.1038/Srep45554 |
0.388 |
|
| 2017 |
Kim SH, Kim S, Nam BH, Lee SE, Kim CS, Seo IY, Kim TN, Hong SH, Kwon TG, Seo SI, Joo KJ, Song K, Kwak C, Chung J. Primary Tumor Characteristics Are Important Prognostic Factors for Sorafenib-Treated Patients with Metastatic Renal Cell Carcinoma: A Retrospective Multicenter Study. Biomed Research International. 2017: 9215930. PMID 28271073 DOI: 10.1155/2017/9215930 |
0.33 |
|
| 2017 |
Lee Y, Han JY, Moon SH, Nam BH, Lim KY, Lee GK, Kim HT, Yun T, An HJ, Lee JS. Incorporating Erlotinib or Irinotecan Plus Cisplatin into Chemoradiotherapy for Stage III Non-small Cell Lung Cancer According to EGFR Mutation Status. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 28111430 DOI: 10.4143/Crt.2016.522 |
0.305 |
|
| 2017 |
Kim JH, Kim JW, Kim SH, Lee Y, Hwang IG, Song H, Koh S, Ko YH, Shin S, Woo IS, Hong S, Kim TY, Kim SY, Nam B, Kim HJ, et al. Predicting cumulative incidence of chemotherapy toxicity in older patients with cancer: Korean Cancer Study Group prospective cohort study (KCSG) PC 13-09. Journal of Clinical Oncology. 35. DOI: 10.1200/Jco.2017.35.15_Suppl.E21539 |
0.361 |
|
| 2017 |
Lim MC, Chang S, Yoo HJ, Nam B, Bristow R, Park S. Randomized trial of hyperthermic intraperitoneal chemotherapy (HIPEC) in women with primary advanced peritoneal, ovarian, and tubal cancer. Journal of Clinical Oncology. 35: 5520-5520. DOI: 10.1200/Jco.2017.35.15_Suppl.5520 |
0.343 |
|
| 2017 |
Ryu KW, Kim YW, Min JS, Yoon HM, An JY, Eom BW, Hur H, Lee Y, Cho GS, Park Y, Jung MR, Park J, Hyung WJ, Jeong S, Nam B. Results of interim analysis of the multicenter randomized phase III SENORITA trial of laparoscopic sentinel node oriented, stomach-preserving surgery versus laparoscopic standard gastrectomy with lymph node dissection in early gastric cancer. Journal of Clinical Oncology. 35: 4028-4028. DOI: 10.1200/Jco.2017.35.15_Suppl.4028 |
0.332 |
|
| 2016 |
Choi SI, Yu A, Kim BH, Ko EJ, Park SS, Nam BH, Park JW. A Model Predicting Survival of Patients with Recurrent or Progressive Hepatocellular Carcinoma: The MORE Score. Journal of Gastroenterology and Hepatology. PMID 27519171 DOI: 10.1111/Jgh.13532 |
0.31 |
|
| 2016 |
Eom BW, Kim YI, Kim KH, Yoon HM, Cho SJ, Lee JY, Kim CG, Kook MC, Kim YW, Nam BH, Ryu KW, Choi IJ. Survival benefit of additional surgery after non-curative endoscopic resection in patients with early gastric cancer. Gastrointestinal Endoscopy. PMID 27460389 DOI: 10.1200/Jco.2016.34.4_Suppl.106 |
0.34 |
|
| 2016 |
Yu A, Woo SM, Joo J, Yang HR, Lee WJ, Park SJ, Nam BH. Development and Validation of a Prediction Model to Estimate Individual Risk of Pancreatic Cancer. Plos One. 11: e0146473. PMID 26752291 DOI: 10.1371/Journal.Pone.0146473 |
0.36 |
|
| 2016 |
Ryu KW, Park JY, Kim YW, Nam B, Lee YJ, Jeong S, Park J, Hur H, Han SU, Min J, An JY, Hyung WJ, Cho GS, Jeong GA, Jeong O, et al. Assessment of laparoscopic stomach preserving surgery with sentinel basin dissection compared with standard gastrectomy with lymphadenectomy in early gastric cancer: A study protocol of a multicenter randomized phase III clinical trial (SENORITA trial). Journal of Clinical Oncology. 34: TPS179-TPS179. DOI: 10.1200/Jco.2016.34.4_Suppl.Tps179 |
0.346 |
|
| 2016 |
Kim JW, Kim K, Lee JH, Hong YS, Kim SY, Park SR, Nam B, Lee K, Chung I, Park YS, Kim JH, Kim TW. Efficacy and safety of FOLFIRI regimen in elderly versus nonelderly patients with advanced colorectal and gastric cancer. Journal of Clinical Oncology. 34: 701-701. DOI: 10.1200/Jco.2016.34.4_Suppl.701 |
0.322 |
|
| 2016 |
Kim YW, Park Y, Yoon HM, Park JY, Ryu KW, Lee Y, Jeong O, Yoon KY, Lee JH, Lee SE, Yu W, Jeong S, Kim T, Kim S, Nam B. Laparoscopy-assisted versus open D2 distal gastrectomy for advanced gastric cancer: Results from a randomized phase II multicenter clinical trial (COACT 1001). Journal of Clinical Oncology. 34: 4028-4028. DOI: 10.1200/Jco.2016.34.15_Suppl.4028 |
0.362 |
|
| 2016 |
Kang Y, Ryu M, Park SH, Park SR, Kim JG, Kim JW, Cho SH, Park YI, Rha SY, Kang MJ, Cho JY, Kang SY, Hong YS, Ryoo B, Nam B, et al. Efficacy and safety findings from DREAM: A phase III study of DHP107 (oral paclitaxel) vs IV paclitaxel in patients with gastric cancer after failure of first-line chemotherapy. Journal of Clinical Oncology. 34: 4016-4016. DOI: 10.1200/Jco.2016.34.15_Suppl.4016 |
0.35 |
|
| 2015 |
Yoon M, Kim N, Nam B, Joo J, Ki M. Changing trends in colorectal cancer in the Republic of Korea: contrast with Japan. Epidemiology and Health. 37: e2015038. PMID 26493653 DOI: 10.4178/Epih/E2015038 |
0.335 |
|
| 2015 |
Kim SH, Kim S, Nam BH, Lee SE, Kim CS, Seo IY, Kim TN, Hong SH, Kwon TG, Seo SI, Joo KJ, Song K, Kwak C, Chung J. Efficacy and Safety of Sorafenib Therapy on Metastatic Renal Cell Carcinoma in Korean Patients: Results from a Retrospective Multicenter Study. Plos One. 10: e0135165. PMID 26308612 DOI: 10.1371/Journal.Pone.0135165 |
0.328 |
|
| 2015 |
Eom BW, Joo J, Kim S, Shin A, Yang HR, Park J, Choi IJ, Kim YW, Kim J, Nam BH. Prediction Model for Gastric Cancer Incidence in Korean Population. Plos One. 10: e0132613. PMID 26186332 DOI: 10.1371/Journal.Pone.0132613 |
0.394 |
|
| 2015 |
Kim SI, Lim MC, Lee JS, Kim YJ, Seo SS, Kang S, Yoo CW, Nam BH, Kim JY, Chung SH, Park SY. Comparison of Lower Extremity Edema in Locally Advanced Cervical Cancer: Pretreatment Laparoscopic Surgical Staging with Tailored Radiotherapy Versus Primary Radiotherapy. Annals of Surgical Oncology. PMID 26059654 DOI: 10.1245/S10434-015-4653-6 |
0.351 |
|
| 2015 |
Park YH, Jung KH, Im SA, Sohn JH, Ro J, Ahn JH, Kim SB, Nam BH, Oh do Y, Han SW, Lee S, Park IH, Lee KS, Kim JH, Kang SY, et al. Quality of life (QoL) in metastatic breast cancer patients with maintenance paclitaxel plus gemcitabine (PG) chemotherapy: results from phase III, multicenter, randomized trial of maintenance chemotherapy versus observation (KCSG-BR07-02). Breast Cancer Research and Treatment. 152: 77-85. PMID 26033708 DOI: 10.1016/S0960-9776(13)70112-7 |
0.324 |
|
| 2015 |
Lee JH, Nam BH, Ryu KW, Ryu SY, Kim YW, Park YK, Kim S. Comparison of the long-term results of patients who underwent laparoscopy versus open distal gastrectomy. Surgical Endoscopy. PMID 25875090 DOI: 10.1007/S00464-015-4215-9 |
0.342 |
|
| 2015 |
Lim SK, Lee MH, Park IH, You JY, Nam BH, Kim BN, Ro J, Lee KS, Jung SY, Kwon YM, Lee ES. Impact of Molecular Subtype Conversion of Breast Cancers after Neoadjuvant Chemotherapy on Clinical Outcome. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 25865655 DOI: 10.4143/Crt.2014.262 |
0.326 |
|
| 2015 |
Choi IJ, Kim YW, Lee HS, Ryu KW, Yoon HM, Eom BW, Kim CG, Lee JY, Cho SJ, Nam BH. Risk Factors for Tuberculosis in Patients with Early Gastric Cancer: Is Gastrectomy a Significant Risk Factor for Tuberculosis? Chest. PMID 25811396 DOI: 10.1378/Chest.15-0056 |
0.355 |
|
| 2015 |
Eom BW, Ryu KW, Nam BH, Park Y, Lee HJ, Kim MC, Cho GS, Kim CY, Ryu SW, Shin DW, Hyung WJ, Lee JH. Survival nomogram for curatively resected Korean gastric cancer patients: multicenter retrospective analysis with external validation. Plos One. 10: e0119671. PMID 25723182 DOI: 10.1371/Journal.Pone.0119671 |
0.416 |
|
| 2015 |
Kim Y, Park J, Nam BH, Ki M. Stomach cancer incidence rates among Americans, Asian Americans and Native Asians from 1988 to 2011. Epidemiology and Health. 37: e2015006. PMID 25687951 DOI: 10.4178/Epih/E2015006 |
0.338 |
|
| 2015 |
Jo MJ, Park JY, Song JS, Kook MC, Ryu KW, Cho SJ, Lee JH, Nam BH, Hong EK, Choi IJ, Kim YW. Biopathologic features and clinical significance of micrometatasis in the lymph node of early gastric cancer. World Journal of Gastroenterology : Wjg. 21: 667-74. PMID 25593497 DOI: 10.3748/Wjg.V21.I2.667 |
0.345 |
|
| 2015 |
Lee JH, Choi IJ, Han HS, Kim YW, Ryu KW, Yoon HM, Eom BW, Kim CG, Lee JY, Cho SJ, Kim YI, Nam BH, Kook MC. Risk of lymph node metastasis in differentiated type mucosal early gastric cancer mixed with minor undifferentiated type histology. Annals of Surgical Oncology. 22: 1813-9. PMID 25344305 DOI: 10.1245/S10434-014-4167-7 |
0.328 |
|
| 2015 |
Choi IJ, Lee JH, Kim YI, Kim CG, Cho SJ, Lee JY, Ryu KW, Nam BH, Kook MC, Kim YW. Long-term outcome comparison of endoscopic resection and surgery in early gastric cancer meeting the absolute indication for endoscopic resection. Gastrointestinal Endoscopy. 81: 333-41.e1. PMID 25281498 DOI: 10.1016/J.Gie.2014.07.047 |
0.328 |
|
| 2015 |
Oh SC, Ryu M, Park SH, Ryoo B, Park SR, Kim JG, Kim JW, Chung I, Park YI, Rha SY, Kang MJ, Cho JY, Kang SY, Hong YS, Nam B, et al. A phase III study to compare efficacy and safety of DHP107 (oral paclitaxel) versus IV paclitaxel in patients with metastatic or recurrent gastric cancer after failure of first-line chemotherapy (DREAM). Journal of Clinical Oncology. 33: TPS4138-TPS4138. DOI: 10.1200/Jco.2015.33.15_Suppl.Tps4138 |
0.383 |
|
| 2015 |
Ryu M, Cho JY, Zang DY, Lee WK, Lee K, Shin DB, Nam B, Lee SS, Lee HW, Kim JG, Kim J, Hwang IG, Baek JH, Yoo CH, Kang Y. A randomized phase III study of adjuvant capecitabine vs observation in curatively resected stage IB (by AJCC 6th edition) gastric cancer (CATALYSIS; KCSG ST14-05). Journal of Clinical Oncology. 33: TPS4137-TPS4137. DOI: 10.1200/Jco.2015.33.15_Suppl.Tps4137 |
0.375 |
|
| 2015 |
Han J, Lee JS, Lee KH, Kim S, Min YJ, Cho EK, Lee YJ, Lee S, Kim HY, Lee GK, Nam B, Han JH, Kim JY, Jung J. A phase II, single-arm, efficacy and safety study of poziotinib (NOV120101) in Korean patients with advanced or metastatic lung adenocarcinoma who have acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors. Journal of Clinical Oncology. 33: 8085-8085. DOI: 10.1200/Jco.2015.33.15_Suppl.8085 |
0.314 |
|
| 2015 |
Kim K, Kim TW, Hong YS, Kim SY, Park SR, Nam B, Lee K, Kim JH, Chung I, Park YS. Modified FOLFIRI (Irinotecan 150 mg/m2) compared to FOLFIRI (Irinotecan 180 mg/m2) in Korean patients with gastrointestinal cancer. Journal of Clinical Oncology. 33: 3600-3600. DOI: 10.1200/Jco.2015.33.15_Suppl.3600 |
0.389 |
|
| 2014 |
Kang Y, Lee KH, Shen L, Yeh K, Hong YS, Park YI, Yang SH, Shin DB, Zang DY, Kang WK, Chung IJ, Kim YH, Ryoo B, Park SR, Nam B, et al. 615ORANDOMIZED PHASE II STUDY OF CAPECITABINE AND CISPLATIN WITH OR WITHOUT SORAFENIB IN PATIENTS WITH METASTATIC GASTRIC CANCER: STARGATE STUDY. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 25: iv210. PMID 28172045 DOI: 10.1093/Annonc/Mdu334.1 |
0.358 |
|
| 2014 |
Kim HS, Koh JS, Choi YB, Ro J, Kim HK, Kim MK, Nam BH, Kim KT, Chandra V, Seol HS, Noh WC, Kim EK, Park J, Bae CD, Hong KM. Chromatin CKAP2, a new proliferation marker, as independent prognostic indicator in breast cancer. Plos One. 9: e98160. PMID 24887265 DOI: 10.1371/Journal.Pone.0098160 |
0.355 |
|
| 2014 |
Shin A, Joo J, Yang HR, Bak J, Park Y, Kim J, Oh JH, Nam BH. Risk prediction model for colorectal cancer: National Health Insurance Corporation study, Korea. Plos One. 9: e88079. PMID 24533067 DOI: 10.1371/Journal.Pone.0088079 |
0.37 |
|
| 2014 |
Kwak HW, Park JW, Nam BH, Yu A, Woo SM, Kim TH, Kim SH, Koh YH, Kim HB, Park SJ, Lee WJ, Hong EK, Kim CM. Clinical outcomes of a cohort series of patients with hepatocellular carcinoma in a hepatitis B virus-endemic area. Journal of Gastroenterology and Hepatology. 29: 820-9. PMID 24325272 DOI: 10.1111/Jgh.12470 |
0.336 |
|
| 2014 |
Hong YS, Nam B, Kim K, Lee J, Park JO, Park YS, Kim SY, Kim T, Kim JH, Ahn JB, Jung KH, Kim TW. Adjuvant chemotherapy with oxaliplatin/5-fluorouracil/leucovorin (FOLFOX) versus 5-fluorouracil/leucovorin (FL) for rectal cancer patients whose postoperative yp stage 2 or 3 after preoperative chemoradiotherapy: Updated results of 3-year disease-free survival from a randomized phase II study (The ADORE). Journal of Clinical Oncology. 32: 3502-3502. DOI: 10.1200/Jco.2014.32.15_Suppl.3502 |
0.399 |
|
| 2013 |
Kang YK, Ryu MH, Yoo C, Ryoo BY, Kim HJ, Lee JJ, Nam BH, Ramaiya N, Jagannathan J, Demetri GD. Resumption of imatinib to control metastatic or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib (RIGHT): a randomised, placebo-controlled, phase 3 trial. The Lancet. Oncology. 14: 1175-82. PMID 24140183 DOI: 10.1016/S1470-2045(13)70453-4 |
0.328 |
|
| 2013 |
Kwon WA, Cho IC, Yu A, Nam BH, Joung JY, Seo HK, Lee KH, Chung J. Validation of the MSKCC and Heng risk criteria models for predicting survival in patients with metastatic renal cell carcinoma treated with sunitinib. Annals of Surgical Oncology. 20: 4397-404. PMID 24081805 DOI: 10.1245/S10434-013-3290-1 |
0.317 |
|
| 2013 |
Park S, Nam BH, Yang HR, Lee JA, Lim H, Han JT, Park IS, Shin HR, Lee JS. Individualized risk prediction model for lung cancer in Korean men. Plos One. 8: e54823. PMID 23408946 DOI: 10.1371/Journal.Pone.0054823 |
0.357 |
|
| 2013 |
Lee KS, Park IH, Nam BH, Ro J. Phase II study of irinotecan plus capecitabine in anthracycline- and taxane- pretreated patients with metastatic breast cancer. Investigational New Drugs. 31: 152-9. PMID 22562702 DOI: 10.1007/S10637-012-9824-8 |
0.354 |
|
| 2013 |
Kim YW, Park Y, Yoon HM, Nam B, Ryu KW, Lee Y, Jeong O, Yoon KY, Lee JH, Lee SE, Yu W, Jeong S, Kim T. Result of clinical study on feasibility of laparoscopy-assisted D2 distal gastrectomy to treat advanced gastric cancer (COACT_1001). Journal of Clinical Oncology. 31: 4105-4105. DOI: 10.1200/Jco.2013.31.15_Suppl.4105 |
0.375 |
|
| 2013 |
Park S, Nam B, Lee WJ, Woo SM, Han SS, Joo J. Development and validation of a predictive model to assess an individual’s risk of pancreatic cancer Pancreatology. 13: S14. DOI: 10.1200/Jco.2013.31.15_Suppl.4045 |
0.358 |
|
| 2013 |
Hong YS, Nam B, Jung KH, Lee J, Kim K, Park YS, Park JO, Kim SY, Kim T, Kim JH, Ahn JB, Kim TW. Adjuvant chemotherapy with oxaliplatin/5-fluorouracil/leucovorin (FOLFOX) versus 5-fluorouracil/leucovorin (FL) in patients with locally advanced rectal cancer after preoperative chemoradiotherapy followed by surgery: A randomized phase II study (The ADORE). Journal of Clinical Oncology. 31: 3570-3570. DOI: 10.1200/Jco.2013.31.15_Suppl.3570 |
0.333 |
|
| 2013 |
Park SR, Kong S, Kim M, Kim MK, Nam B, Choi M, Park Y. Abstract LB-172: A randomized phase II study of S-1 versus capecitabine as first-line chemotherapy in the elderly metastatic gastric cancer patients with/without poor performance status: clinical and pharmacogenetic results. Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-Lb-172 |
0.361 |
|
| 2012 |
Nam JH, Choi IJ, Cho SJ, Kim CG, Jun JK, Choi KS, Nam BH, Lee JH, Ryu KW, Kim YW. Association of the interval between endoscopies with gastric cancer stage at diagnosis in a region of high prevalence. Cancer. 118: 4953-60. PMID 22806878 DOI: 10.1002/Cncr.27495 |
0.389 |
|
| 2012 |
Lee SE, Lee JH, Ryu KW, Nam BH, Cho SJ, Lee JY, Kim CG, Choi IJ, Kook MC, Park SR, Kim YW. Preoperative plasma fibrinogen level is a useful predictor of adjacent organ involvement in patients with advanced gastric cancer. Journal of Gastric Cancer. 12: 81-7. PMID 22792520 DOI: 10.5230/Jgc.2012.12.2.81 |
0.348 |
|
| 2012 |
Kang S, Nam BH, Park JY, Seo SS, Ryu SY, Kim JW, Kim SC, Park SY, Nam JH. Risk assessment tool for distant recurrence after platinum-based concurrent chemoradiation in patients with locally advanced cervical cancer: a Korean gynecologic oncology group study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 2369-74. PMID 22614984 DOI: 10.1200/Jco.2011.37.5923 |
0.371 |
|
| 2012 |
Han MA, Oh MG, Choi IJ, Park SR, Ryu KW, Nam BH, Cho SJ, Kim CG, Lee JH, Kim YW. Association of family history with cancer recurrence and survival in patients with gastric cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 701-8. PMID 22271486 DOI: 10.1200/Jco.2011.35.3078 |
0.382 |
|
| 2012 |
Eom BW, Lee JH, Choi IJ, Kook MC, Nam BH, Ryu KW, Kim YW. Pretreatment risk factors for multiple gastric cancer and missed lesions. Journal of Surgical Oncology. 105: 813-7. PMID 22006627 DOI: 10.1002/Jso.22124 |
0.372 |
|
| 2012 |
Park IH, Lee KS, Kang HS, Kim SW, Lee S, Jung SY, Kwon Y, Shin KH, Ko K, Nam BH, Ro J. A phase Ib study of preoperative lapatinib, paclitaxel, and gemcitabine combination therapy in women with HER2 positive early breast cancer. Investigational New Drugs. 30: 1972-7. PMID 22006161 DOI: 10.1200/Jco.2011.29.15_Suppl.E11069 |
0.307 |
|
| 2012 |
Eom BW, Lee JH, Lee JS, Kim MJ, Ryu KW, Choi IJ, Cho SJ, Lee JY, Rhee J, Nam BH, Kim YW. Survival analysis of gastric cancer patients with tumor thrombus in the portal vein. Journal of Surgical Oncology. 105: 310-5. PMID 21898415 DOI: 10.1002/Jso.22083 |
0.36 |
|
| 2012 |
Eom BW, Jo MJ, Kook MC, Ryu KW, Choi IJ, Nam BH, Kim YW, Lee JH. The lymphangiogenic factor SOX 18: a key indicator to stage gastric tumor progression. International Journal of Cancer. Journal International Du Cancer. 131: 41-8. PMID 21796627 DOI: 10.1002/Ijc.26325 |
0.37 |
|
| 2012 |
Jeong JH, Jung SY, Park IH, Lee KS, Kang HS, Kim SW, Kwon Y, Kim EA, Ko KL, Nam BH, Lee S, Ro J. Predictive factors of pathologic complete response and clinical tumor progression after preoperative chemotherapy in patients with stage II and III breast cancer. Investigational New Drugs. 30: 408-16. PMID 20922557 DOI: 10.1007/S10637-010-9555-7 |
0.35 |
|
| 2012 |
Park SR, Park Y, Rhee J, Nam B, Kong S, Kim SH, Choi M, Choi IJ, Kim CG, Lee JY, Cho S, Kim YW, Ryu KW, Lee JH, Kim NK. A randomized phase II study of continuous versus intermittent S-1 plus oxaliplatin in first-line treatment of patients with metastatic gastric carcinoma. Journal of Clinical Oncology. 30: 4028-4028. DOI: 10.1200/Jco.2012.30.15_Suppl.4028 |
0.349 |
|
| 2012 |
Nam B, Bak J, Kim J. Abstract 5433: Dietary factors and the risk of esophageal cancer: A population-based cohort study in Korea Cancer Research. 72: 5433-5433. DOI: 10.1158/1538-7445.Am2012-5433 |
0.357 |
|
| 2012 |
Kim GM, Jeung H, Kwon WS, Rha SY, Kim HS, Jung I, Nam B, Lee KH, Chung HC. Abstract 3689: Association of thymidylate synthase gene polymorphisms with efficacy and toxicity of oral fluoropyrimidine based chemotherapy in advanced gastric cancer Cancer Research. 72: 3689-3689. DOI: 10.1158/1538-7445.Am2012-3689 |
0.328 |
|
| 2012 |
Kim H, Park HJ, Won CS, Jeon HK, Park D, Cha JM, Park S, Choi H, Shin JE, Eun CS, Kim J, Kim HG, Kim S, Park CH, Kim TI, ... ... Nam B, et al. 442 Technological Assistance of Cap-Assisted Chromoendoscopy Enhances the Detection Rates of Both Colorectal Adenoma and Proximal Serrated Polyp in an Average-Risk Screening Population: Preliminary Results of a Multi-Center Randomized Controlled Trial Gastrointestinal Endoscopy. 75: AB139. DOI: 10.1016/J.Gie.2012.04.059 |
0.312 |
|
| 2011 |
Ryu SY, Lee W, Kim K, Park S, Kim B, Kim M, Choi S, Nam B, Cho C. Are there any candidates for adjuvant hysterectomy among patients with locally advanced bulky cervical cancer initially treated with cisplatin-based chemoradiation? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: e15504. PMID 28023886 DOI: 10.1200/Jco.2011.29.15_Suppl.E15504 |
0.347 |
|
| 2011 |
Choi CM, Jang SJ, Park SY, Choi YB, Jeong JH, Kim DS, Kim HK, Park KS, Nam BH, Kim HR, Kim SY, Hong KM. Transglutaminase 2 as an independent prognostic marker for survival of patients with non-adenocarcinoma subtype of non-small cell lung cancer. Molecular Cancer. 10: 119. PMID 21943122 DOI: 10.1186/1476-4598-10-119 |
0.357 |
|
| 2011 |
Yun T, Han JY, Lee JS, Choi HL, Kim HY, Nam BH, Kim HT. Phase II study of weekly paclitaxel and capecitabine in patients with metastatic or recurrent esophageal squamous cell carcinoma. Bmc Cancer. 11: 385. PMID 21888637 DOI: 10.1186/1471-2407-11-385 |
0.334 |
|
| 2011 |
Ryu SY, Lee WM, Kim K, Park SI, Kim BJ, Kim MH, Choi SC, Cho CK, Nam BH, Lee ED. Randomized clinical trial of weekly vs. triweekly cisplatin-based chemotherapy concurrent with radiotherapy in the treatment of locally advanced cervical cancer. International Journal of Radiation Oncology, Biology, Physics. 81: e577-81. PMID 21840137 DOI: 10.1016/J.Ijrobp.2011.05.002 |
0.344 |
|
| 2011 |
Kim JY, Wie GA, Cho YA, Kim SY, Kim SM, Son KH, Park SJ, Nam BH, Joung H. Development and validation of a nutrition screening tool for hospitalized cancer patients. Clinical Nutrition (Edinburgh, Scotland). 30: 724-9. PMID 21813215 DOI: 10.1016/J.Clnu.2011.06.001 |
0.336 |
|
| 2011 |
Keam B, Im SA, Park S, Nam BH, Han SW, Oh DY, Kim JH, Lee SH, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Bang YJ. Nomogram predicting clinical outcomes in breast cancer patients treated with neoadjuvant chemotherapy. Journal of Cancer Research and Clinical Oncology. 137: 1301-8. PMID 21717200 DOI: 10.1007/S00432-011-0991-3 |
0.368 |
|
| 2011 |
Ryu KW, Eom BW, Nam BH, Lee JH, Kook MC, Choi IJ, Kim YW. Is the sentinel node biopsy clinically applicable for limited lymphadenectomy and modified gastric resection in gastric cancer? A meta-analysis of feasibility studies. Journal of Surgical Oncology. 104: 578-84. PMID 21695700 DOI: 10.1002/Jso.21995 |
0.386 |
|
| 2011 |
Park IH, Lee YS, Lee KS, Kim SY, Hong SH, Jeong J, Lee H, Ro J, Nam BH. Single nucleotide polymorphisms of CYP19A1 predict clinical outcomes and adverse events associated with letrozole in patients with metastatic breast cancer. Cancer Chemotherapy and Pharmacology. 68: 1263-71. PMID 21442439 DOI: 10.1007/S00280-011-1615-Y |
0.316 |
|
| 2011 |
Ryu SY, Park SI, Nam BH, Cho CK, Kim K, Kim BJ, Kim MH, Choi SC, Lee ED, Lee KH. Is adjuvant chemoradiotherapy overtreatment in cervical cancer patients with intermediate risk factors? International Journal of Radiation Oncology, Biology, Physics. 79: 794-9. PMID 20421158 DOI: 10.1016/J.Ijrobp.2009.11.019 |
0.377 |
|
| 2011 |
Park SR, Kong S, Nam B, Choi IJ, Kim CG, Lee JY, Cho S, Kim Y, Ryu KW, Lee JH, Rhee J, Park Y, Kim NK. Abstract 5450:CYP2A6andERCC1polymorphisms correlate with efficacy of S-1 plus cisplatin in metastatic gastric cancer patients Cancer Research. 71: 5450-5450. DOI: 10.1158/1538-7445.Am2011-5450 |
0.344 |
|
| 2010 |
Cho SJ, Choi IJ, Kim CG, Lee JY, Kook MC, Seong MW, Park SR, Lee JS, Kim YW, Ryu KW, Lee JH, Nam BH, Park YI. Helicobacter pylori Seropositivity Is Associated with Gastric Cancer Regardless of Tumor Subtype in Korea. Gut and Liver. 4: 466-74. PMID 21253294 DOI: 10.5009/Gnl.2010.4.4.466 |
0.319 |
|
| 2010 |
Eom BW, Yoon H, Ryu KW, Lee JH, Cho SJ, Lee JY, Kim CG, Choi IJ, Lee JS, Kook MC, Park SR, Nam BH, Kim YW. Predictors of timing and patterns of recurrence after curative resection for gastric cancer. Digestive Surgery. 27: 481-6. PMID 21063125 DOI: 10.1159/000320691 |
0.332 |
|
| 2010 |
Yoo CW, Nam BH, Kim JY, Shin HJ, Lim H, Lee S, Lee SK, Lim MC, Song YJ. Carbonic anhydrase XII expression is associated with histologic grade of cervical cancer and superior radiotherapy outcome. Radiation Oncology (London, England). 5: 101. PMID 21040567 DOI: 10.1186/1748-717X-5-101 |
0.302 |
|
| 2010 |
Kim MS, Lee HS, Lee JM, Zo JI, Lee GK, Nam BH. Prognostic value of single nodal zone metastasis in non-small-cell lung cancer. European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association For Cardio-Thoracic Surgery. 38: 491-7. PMID 20399672 DOI: 10.1016/J.Ejcts.2010.02.033 |
0.372 |
|
| 2010 |
Kim J, Park S, Nam BH. Gastric cancer and salt preference: a population-based cohort study in Korea. The American Journal of Clinical Nutrition. 91: 1289-93. PMID 20219954 DOI: 10.3945/Ajcn.2009.28732 |
0.415 |
|
| 2010 |
Park SR, Kim MJ, Ryu KW, Lee JH, Lee JS, Nam BH, Choi IJ, Kim YW. Prognostic value of preoperative clinical staging assessed by computed tomography in resectable gastric cancer patients: a viewpoint in the era of preoperative treatment. Annals of Surgery. 251: 428-35. PMID 20179530 DOI: 10.1097/Sla.0B013E3181Ca69A7 |
0.382 |
|
| 2010 |
Kang S, Kim SK, Chung DC, Seo SS, Kim JY, Nam BH, Park SY. Diagnostic value of (18)F-FDG PET for evaluation of paraaortic nodal metastasis in patients with cervical carcinoma: a metaanalysis. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 360-7. PMID 20150275 DOI: 10.2967/Jnumed.109.066217 |
0.317 |
|
| 2010 |
Jung SY, Kim HY, Nam BH, Min SY, Lee SJ, Park C, Kwon Y, Kim EA, Ko KL, Shin KH, Lee KS, Park IH, Lee S, Kim SW, Kang HS, et al. Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer. Breast Cancer Research and Treatment. 120: 627-37. PMID 20143153 DOI: 10.1007/S10549-010-0780-8 |
0.371 |
|
| 2010 |
Kang S, Kim TJ, Nam BH, Seo SS, Kim BG, Bae DS, Park SY. Preoperative serum CA-125 levels and risk of suboptimal cytoreduction in ovarian cancer: a meta-analysis. Journal of Surgical Oncology. 101: 13-7. PMID 20025071 DOI: 10.1002/Jso.21398 |
0.306 |
|
| 2010 |
Shin A, Bak J, Kim J, Park S, Nam B. Abstract LB-396: Site-specific risk factors for colorectal cancer among Korean population Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-396 |
0.398 |
|
| 2009 |
Kong SY, Lim HS, Nam BH, Kook MC, Kim YW, Ryu KW, Lee JH, Choi IJ, Lee JS, Park YI, Kim NK, Park SR. Association of CYP2A6 polymorphisms with S-1 plus docetaxel therapy outcomes in metastatic gastric cancer. Pharmacogenomics. 10: 1147-55. PMID 19604090 DOI: 10.2217/Pgs.09.48 |
0.353 |
|
| 2009 |
Kang S, Nam BH. Does neoadjuvant chemotherapy increase optimal cytoreduction rate in advanced ovarian cancer? Meta-analysis of 21 studies Annals of Surgical Oncology. 16: 2315-2320. PMID 19517192 DOI: 10.1245/S10434-009-0558-6 |
0.364 |
|
| 2009 |
Lee JH, Cho YS, Lee JY, Kook MC, Park JW, Nam BH, Bae JM. The chemokine receptor CCR4 is expressed and associated with a poor prognosis in patients with gastric cancer. Annals of Surgery. 249: 933-41. PMID 19474687 DOI: 10.1097/Sla.0B013E3181A77Ccc |
0.352 |
|
| 2009 |
Lee SE, Kim YW, Lee JH, Ryu KW, Cho SJ, Lee JY, Kim CG, Choi IJ, Kook MC, Nam BH, Park SR, Kim MJ, Lee JS. Developing an institutional protocol guideline for laparoscopy-assisted distal gastrectomy. Annals of Surgical Oncology. 16: 2231-6. PMID 19430842 DOI: 10.1245/S10434-009-0490-9 |
0.324 |
|
| 2009 |
Jo MJ, Lee JH, Nam BH, Kook MC, Ryu KW, Choi IJ, Kim YW, Bae JM. Preoperative serum angiopoietin-2 levels correlate with lymph node status in patients with early gastric cancer. Annals of Surgical Oncology. 16: 2052-7. PMID 19408052 DOI: 10.1245/S10434-009-0474-9 |
0.356 |
|
| 2009 |
Ryu J, Nam BH, Jung YS. Clinical outcomes comparing parenteral and nasogastric tube nutrition after laryngeal and pharyngeal cancer surgery. Dysphagia. 24: 378-86. PMID 19255706 DOI: 10.1007/S00455-009-9213-4 |
0.309 |
|
| 2009 |
Lee KS, Ro J, Lee ES, Kang HS, Kim SW, Nam BH, Kwon Y, Kim EA, Shin KH. Primary systemic therapy with intermittent weekly paclitaxel plus gemcitabine in patients with stage II and III breast cancer: a phase II trial. Investigational New Drugs. 28: 83-90. PMID 19229476 DOI: 10.1007/S10637-009-9229-5 |
0.333 |
|
| 2009 |
Lee SE, Lee JH, Ryu KW, Cho SJ, Lee JY, Kim CG, Choi IJ, Kook MC, Nam BH, Park SR, Lee JS, Kim YW. Sentinel node mapping and skip metastases in patients with early gastric cancer. Annals of Surgical Oncology. 16: 603-8. PMID 19127361 DOI: 10.1245/S10434-008-0283-6 |
0.371 |
|
| 2009 |
Lee JH, Ryu KW, Nam BH, Kook MC, Cho SJ, Lee JY, Kim CG, Choi IJ, Park SR, Kim YW. Factors associated with detection failure and false-negative sentinel node biopsy findings in gastric cancer: results of prospective single center trials. Journal of Surgical Oncology. 99: 137-42. PMID 19117015 DOI: 10.1002/Jso.21222 |
0.366 |
|
| 2009 |
Kim CG, Choi IJ, Lee JY, Cho SJ, Nam BH, Kook MC, Hong EK, Kim YW. Biopsy site for detecting Helicobacter pylori infection in patients with gastric cancer. Journal of Gastroenterology and Hepatology. 24: 469-74. PMID 19067779 DOI: 10.1111/J.1440-1746.2008.05679.X |
0.33 |
|
| 2008 |
Lee JH, Ryu KW, Kook MC, Lee JY, Kim CG, Choi IJ, Kim SK, Jang S, Park SR, Kim YW, Nam BH, Bae JM. Feasibility of laparoscopic sentinel basin dissection for limited resection in early gastric cancer. Journal of Surgical Oncology. 98: 331-5. PMID 18646047 DOI: 10.1002/Jso.21115 |
0.352 |
|
| 2008 |
Han HS, Ro J, Lee KS, Nam BH, Seo JA, Lee DH, Lee H, Lee ES, Kang HS, Kim SW. Analysis of chemotherapy-induced amenorrhea rates by three different anthracycline and taxane containing regimens for early breast cancer. Breast Cancer Research and Treatment. 115: 335-42. PMID 18506620 DOI: 10.1007/S10549-008-0071-9 |
0.325 |
|
| 2008 |
Ryu KW, Kim YW, Lee JH, Nam BH, Kook MC, Choi IJ, Bae JM. Surgical complications and the risk factors of laparoscopy-assisted distal gastrectomy in early gastric cancer. Annals of Surgical Oncology. 15: 1625-31. PMID 18340493 DOI: 10.1245/S10434-008-9845-X |
0.351 |
|
| 2008 |
Nam BH, Kim SY, Han HS, Kwon Y, Lee KS, Kim TH, Ro J. Breast cancer subtypes and survival in patients with brain metastases. Breast Cancer Research : Bcr. 10: R20. PMID 18307763 DOI: 10.1186/Bcr1870 |
0.309 |
|
| 2007 |
Dhingra R, Gona P, Nam BH, D'Agostino RB, Wilson PW, Benjamin EJ, O'Donnell CJ. C-reactive protein, inflammatory conditions, and cardiovascular disease risk. The American Journal of Medicine. 120: 1054-62. PMID 18060926 DOI: 10.1016/J.Amjmed.2007.08.037 |
0.409 |
|
| 2007 |
Lee JH, Kim YW, Ryu KW, Lee JR, Kim CG, Choi IJ, Kook MC, Nam BH, Bae JM. A phase-II clinical trial of laparoscopy-assisted distal gastrectomy with D2 lymph node dissection for gastric cancer patients. Annals of Surgical Oncology. 14: 3148-53. PMID 17705092 DOI: 10.1245/S10434-007-9446-0 |
0.345 |
|
| 2007 |
Lee KS, Ro J, Nam BH, Lee ES, Kwon Y, Kwon HS, Chung KW, Kang HS, Kim EA, Kim SW, Shin KH, Kim SK. A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer. Breast Cancer Research and Treatment. 109: 481-9. PMID 17653851 DOI: 10.1007/S10549-007-9672-Y |
0.381 |
|
| 2007 |
Marrugat J, Subirana I, ComÃn E, Cabezas C, Vila J, Elosua R, Nam BH, Ramos R, Sala J, Solanas P, Cordón F, Gené-Badia J, D'Agostino RB. Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA Study. Journal of Epidemiology and Community Health. 61: 40-7. PMID 17183014 DOI: 10.1136/Jech.2005.038505 |
0.448 |
|
| 2007 |
Kim J, Jeong J, Nam B, Kim S, Cho C, Kim B, Lee J, Kim Y, Bae D, Kang S. A phase II trial of radiation therapy with concurrent paclitaxel chemotherapy in high-risk endometrial cancer patients after staging operation: An interim analysis of a prospective multicenter trial (KGOG2001) Journal of Clinical Oncology. 25: 16069-16069. DOI: 10.1200/Jco.2007.25.18_Suppl.16069 |
0.389 |
|
| 2006 |
Lee JH, Ryu KW, Lee JH, Park SR, Kim CG, Kook MC, Nam BH, Kim YW, Bae JM. Learning curve for total gastrectomy with D2 lymph node dissection: cumulative sum analysis for qualified surgery. Annals of Surgical Oncology. 13: 1175-81. PMID 16947008 DOI: 10.1245/S10434-006-9050-8 |
0.304 |
|
| 2006 |
Arnlöv J, Pencina MJ, Amin S, Nam BH, Benjamin EJ, Murabito JM, Wang TJ, Knapp PE, D'Agostino RB, Bhasin S, Vasan RS. Endogenous sex hormones and cardiovascular disease incidence in men. Annals of Internal Medicine. 145: 176-84. PMID 16880459 DOI: 10.7326/0003-4819-145-3-200608010-00005 |
0.541 |
|
| 2006 |
Lee DS, Pencina MJ, Benjamin EJ, Wang TJ, Levy D, O'Donnell CJ, Nam BH, Larson MG, D'Agostino RB, Vasan RS. Association of parental heart failure with risk of heart failure in offspring. The New England Journal of Medicine. 355: 138-47. PMID 16837677 DOI: 10.1056/Nejmoa052948 |
0.54 |
|
| 2006 |
Park JG, Kim DW, Hong CW, Nam BH, Shin YK, Hong SH, Kim IJ, Lim SB, Aronson M, Bisgaard ML, Brown GJ, Burn J, Chow E, Conrad P, Douglas F, et al. Germ line mutations of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients with small bowel cancer: International Society for Gastrointestinal Hereditary Tumours Collaborative Study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 3389-93. PMID 16740762 DOI: 10.1158/1078-0432.Ccr-05-2452 |
0.33 |
|
| 2006 |
Song SW, Lee HS, Kim MS, Lee JM, Kim JH, Nam BH, Zo JI. Preoperative serum fibrinogen level predicts postoperative pulmonary complications after lung cancer resection. The Annals of Thoracic Surgery. 81: 1974-81. PMID 16731116 DOI: 10.1016/J.Athoracsur.2006.01.032 |
0.35 |
|
| 2006 |
Dhingra R, Pencina MJ, Wang TJ, Nam BH, Benjamin EJ, Levy D, Larson MG, Kannel WB, D'Agostino RB, Vasan RS. Electrocardiographic QRS duration and the risk of congestive heart failure: the Framingham Heart Study. Hypertension. 47: 861-7. PMID 16585411 DOI: 10.1161/01.Hyp.0000217141.20163.23 |
0.546 |
|
| 2006 |
Nam BH, Kannel WB, D'Agostino RB. Search for an optimal atherogenic lipid risk profile: from the Framingham Study. The American Journal of Cardiology. 97: 372-5. PMID 16442398 DOI: 10.1016/J.Amjcard.2005.08.055 |
0.415 |
|
| 2006 |
Lee DH, Han J, Yu SY, Kim HY, Nam B, Hong EK, Kim HT, Lee JS. The Role of Gefitinib Treatment for Korean Never-Smokers with Advanced or Metastatic Adenocarcinoma of the Lung: A Prospective Study Journal of Thoracic Oncology. 1: 965-971. DOI: 10.1016/S1556-0864(15)31642-7 |
0.345 |
|
| 2005 |
Murabito JM, Pencina MJ, Nam BH, D'Agostino RB, Wang TJ, Lloyd-Jones D, Wilson PW, O'Donnell CJ. Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults. Jama. 294: 3117-23. PMID 16380592 DOI: 10.1001/Jama.294.24.3117 |
0.534 |
|
| 2005 |
Wilson PW, Nam BH, Pencina M, D'Agostino RB, Benjamin EJ, O'Donnell CJ. C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study. Archives of Internal Medicine. 165: 2473-8. PMID 16314543 DOI: 10.1001/Archinte.165.21.2473 |
0.59 |
|
| 2005 |
Millen BE, Quatromoni PA, Pencina M, Kimokoti R, Nam BH, Cobain S, Kozak W, Appugliese DP, Ordovas J, D'Agostino RB. Unique dietary patterns and chronic disease risk profiles of adult men: the Framingham nutrition studies. Journal of the American Dietetic Association. 105: 1723-34. PMID 16256756 DOI: 10.1016/J.Jada.2005.08.007 |
0.517 |
|
| 2005 |
Arnlöv J, Pencina MJ, Nam BH, Meigs JB, Fox CS, Levy D, D'Agostino RB, Vasan RS. Relations of insulin sensitivity to longitudinal blood pressure tracking: variations with baseline age, body mass index, and blood pressure. Circulation. 112: 1719-27. PMID 16157770 DOI: 10.1161/Circulationaha.105.535039 |
0.538 |
|
| 2005 |
Millen BE, Quatromoni PA, Nam BH, Pencina MJ, Polak JF, Kimokoti RW, Ordovas JM, D'Agostino RB. Compliance with expert population-based dietary guidelines and lower odds of carotid atherosclerosis in women: the Framingham Nutrition Studies. The American Journal of Clinical Nutrition. 82: 174-80. PMID 16002816 DOI: 10.1093/Ajcn.82.1.174 |
0.566 |
|
| 2005 |
Sonnenberg L, Pencina M, Kimokoti R, Quatromoni P, Nam BH, D'Agostino R, Meigs JB, Ordovas J, Cobain M, Millen B. Dietary patterns and the metabolic syndrome in obese and non-obese Framingham women. Obesity Research. 13: 153-62. PMID 15761175 DOI: 10.1038/Oby.2005.20 |
0.521 |
|
| 2004 |
Kannel WB, Wilson PW, Nam BH, D'Agostino RB, Li J. A likely explanation for the J-curve of blood pressure cardiovascular risk. The American Journal of Cardiology. 94: 380-4. PMID 15276113 DOI: 10.1016/J.Amjcard.2004.04.043 |
0.412 |
|
| 2004 |
Lloyd-Jones DM, Nam BH, D'Agostino RB, Levy D, Murabito JM, Wang TJ, Wilson PW, O'Donnell CJ. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. Jama. 291: 2204-11. PMID 15138242 DOI: 10.1001/Jama.291.18.2204 |
0.357 |
|
| 2004 |
Murabito JM, Nam BH, D'Agostino RB, Lloyd-Jones DM, O'Donnell CJ, Wilson PW. Accuracy of offspring reports of parental cardiovascular disease history: the Framingham Offspring Study. Annals of Internal Medicine. 140: 434-40. PMID 15023709 DOI: 10.7326/0003-4819-140-6-200403160-00010 |
0.346 |
|
| 2004 |
Millen BE, Quatromoni PA, Nam BH, O'Horo CE, Polak JF, Wolf PA, D'Agostino RB. Dietary patterns, smoking, and subclinical heart disease in women: opportunities for primary prevention from the Framingham Nutrition Studies. Journal of the American Dietetic Association. 104: 208-14. PMID 14760568 DOI: 10.1016/J.Jada.2003.11.007 |
0.433 |
|
| 2004 |
Antolini L, Nam BH, D'Agostino RB. Inference on correlated discrimination measures in survival analysis: A nonparametric approach Communications in Statistics - Theory and Methods. 33: 2117-2135. DOI: 10.1081/Sta-200026579 |
0.373 |
|
| 2003 |
Wang TJ, Nam BH, D'Agostino RB, Wolf PA, Lloyd-Jones DM, MacRae CA, Wilson PW, Polak JF, O'Donnell CJ. Carotid intima-media thickness is associated with premature parental coronary heart disease: the Framingham Heart Study. Circulation. 108: 572-6. PMID 12874190 DOI: 10.1161/01.Cir.0000081764.35431.De |
0.32 |
|
| 2003 |
D'Agostino RB, Nam BH. Evaluation of the Performance of Survival Analysis Models: Discrimination and Calibration Measures Handbook of Statistics. 23: 1-25. DOI: 10.1016/S0169-7161(03)23001-7 |
0.401 |
|
| 2002 |
Millen BE, Quatromoni PA, Nam BH, O'Horo CE, Polak JF, D'Agostino RB. Dietary patterns and the odds of carotid atherosclerosis in women: the Framingham Nutrition Studies. Preventive Medicine. 35: 540-7. PMID 12460521 DOI: 10.1006/Pmed.2002.1116 |
0.443 |
|
| 2002 |
Wang TJ, Nam BH, Wilson PW, Wolf PA, Levy D, Polak JF, D'Agostino RB, O'Donnell CJ. Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham Heart Study. Arteriosclerosis, Thrombosis, and Vascular Biology. 22: 1662-7. PMID 12377746 DOI: 10.1161/01.Atv.0000034543.78801.69 |
0.361 |
|
| 2002 |
Kannel WB, Wilson PW, Nam BH, D'Agostino RB. Risk stratification of obesity as a coronary risk factor. The American Journal of Cardiology. 90: 697-701. PMID 12356380 DOI: 10.1016/S0002-9149(02)02592-4 |
0.354 |
|
| 2002 |
Quatromoni PA, Copenhafer DL, Demissie S, D'Agostino RB, O'Horo CE, Nam BH, Millen BE. The internal validity of a dietary pattern analysis. The Framingham Nutrition Studies. Journal of Epidemiology and Community Health. 56: 381-8. PMID 11964437 DOI: 10.1136/jech.56.5.381 |
0.337 |
|
| Show low-probability matches. |